SRP0383
EHMT1 human
recombinant, expressed in E. coli, ≥63% (SDS-PAGE)
Synonym(s):
EHMT1, KMT1D
Sign Into View Organizational & Contract Pricing
All Photos(2)
Select a Size
Change View
50 μG
€488.00
About This Item
UNSPSC Code:
12352200
NACRES:
NA.32
Recommended Products
biological source
human
recombinant
expressed in E. coli
Assay
≥63% (SDS-PAGE)
form
aqueous solution
mol wt
72.4 kDa
packaging
pkg of 50 μg
NCBI accession no.
UniProt accession no.
shipped in
dry ice
storage temp.
−70°C
Gene Information
human ... EHMT1(79813)
General description
Human euchromatic histone-lysine N-methyltransferase (EHMT1), also known as G9a-like protein (GLP) or KMT1D, (GenBank Accession No. NM_024757), amino acids 894-1298 (end) with N-terminal GST-tag, MW= 72.4 kDa, expressed in an E. coli expression system.
Storage Class Code
10 - Combustible liquids
WGK
WGK 1
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Choose from one of the most recent versions:
Certificates of Analysis (COA)
Lot/Batch Number
Don't see the Right Version?
If you require a particular version, you can look up a specific certificate by the Lot or Batch number.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Bassant Orabi et al.
Heart failure reviews, 23(3), 363-376 (2018-04-24)
Glucagon-like peptide-1 (GLP-1) agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors produce some beneficial and deleterious effects in diabetic patients not mediated by their glycemic lowering effects, and there is a need for better understanding of the molecular basis of these effects.
Levi Todd et al.
The Journal of comparative neurology, 524(1), 74-89 (2015-06-09)
Retinal progenitors in the circumferential marginal zone (CMZ) and Müller glia-derived progenitors have been well described for the eyes of fish, amphibians, and birds. However, there is no information regarding a CMZ and the nature of retinal glia in species
Jing Huang et al.
The Journal of biological chemistry, 285(13), 9636-9641 (2010-02-02)
The tumor suppressor p53 is regulated by numerous post-translational modifications. Lysine methylation has recently emerged as a key post-translational modification that alters the activity of p53. Here, we describe a novel lysine methylation site in p53 that is carried out
Yukihiro Itoh et al.
Scientific reports, 9(1), 767-767 (2019-01-27)
In the context of drug design, C-H···O hydrogen bonds have received little attention so far, mostly because they are considered weak relative to other noncovalent interactions such as O-H···O hydrogen bonds, π/π interactions, and van der Waals interactions. Herein, we
Shinichiro Kato et al.
Cancer discovery, 10(7), 980-997 (2020-04-10)
Epigenetic regulators, when genomically altered, may become driver oncogenes that mediate otherwise unexplained pro-oncogenic changes lacking a clear genetic stimulus, such as activation of the WNT/β-catenin pathway in melanoma. This study identifies previously unrecognized recurrent activating mutations in the G9a
Active Filters
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service
